Mayo Clinic Integrating Pharmacogenomics into Clinical Practice: Certificate Program 2022 (Videos + Assessment Quiz)

Upon completion of this activity, participants should be able to:

• Review foundational pharmacogenomics principles.
• Describe what to consider when implementing pharmacogenomics in clinical practice.
• Apply pharmacogenomics test results to make recommendations for an individualized medication management plan.
• Identify barriers and challenges of considering pharmacogenomics in patient care.

Attendance at any Mayo Clinic course does not indicate or guarantee competence or proficiency in the skills, knowledge or performance of any care or procedure(s) which may be discussed or taught in this course.

Program : 

Integrating Pharmacogenomics into Clinical Practice

Pharmacogenomics (PGx) Principles and Concepts

• Pharmacogenomics 101: An Introduction to Foundational Concepts
  Christopher T. Grilli, Pharm.D., R.Ph., M.B.A.
• Variability and Pharmacokinetic Principles
  Wayne T. Nicholson, M.D., Pharm.D.
• Sex, Drugs, and Genetic Variation
  Ann M. Moyer, M.D., Ph.D.
• Pharmacogenomics’ Emerging Role
  Richard Weinshilboum, M.D.
• Pharmacogenomics: Discovery and Translation
  Liewei Wang, M.D., Ph.D.
• Untangling the Polypharmacy Burden with Pharmacogenomics Testing
  Eric T. Matey, Pharm.D., R.Ph.

Pharmacogenomics (PGx) Rules and Regulations

• Legal Implications of Pharmacogenomics Testing
  Sharon C. Zehe, J.D.
• PGx from a Patient Perspective: GINA & Other Important Questions
  Teresa M. Kruisselbrink, M.S., CGC, LCGC

Pharmacogenomics (PGx) Clinical Laboratory Testing

• Clinical Laboratory Testing in PGx: “the Lab” 101
  Ann M. Moyer, M.D., Ph.D.
• Clinical Laboratory Testing in PGx: Targeting Genotyping Technology
  Ann M. Moyer, M.D., Ph.D.
• Clinical Laboratory Testing in PGx: “Sequencing”
  Ann M. Moyer, M.D., Ph.D.
• Clinical Laboratory testing in PGx: “Reporting”
  Ann M. Moyer, M.D., Ph.D.

Pharmacogenomics in Practice: General Principles

• Pharmacogenomics Testing: Role in Clinical Medicine
  Denise M. Dupras, M.D., Ph.D.
• 10 Considerations for the Clinician Applying Pharmacogenomics to Practice
  Wayne T. Nicholson, M.D., Pharm.D.
• Polypharmacy and PGx: Multi-Drug, Herbal/Dietary Supplement Case Study
  Michael J. Schuh, Pharm.D., R.Ph.
• Utilizing National Pharmacogenomics Guidelines and Other Resources
  Jessica A. Wright, Pharm.D., R.Ph.
• Case Review: From My Practice to Yours
  Sheena K. Crosby, Pharm.D., R.Ph.

Pharmacogenomics in Practice: Panel Discussions

• Pharmacogenomics from the Patient Perspective
  Darryl S. Chutka, M.D. (Moderator), Matthew J. Ferber, Ph.D., Karen M. Meagher, Ph.D. & Sharon C. Zehe, J.D.
• Pharmacogenomics from the Clinician Perspective
  Matthew E. Bernard, M.D., Jennifer A. Bold APRN, C.N.P., D.N.P., Darryl S. Chutka, M.D. (Moderator) & Paul Y. Takahashi, M.D.
• Pharmacogenomics from the Pharmacy Perspective
  Christopher Grilli, Pharm.D., R.Ph.,M.B.A. (Moderator), Ashley D. Ebenhoh, Pharm.D., R.Ph., & Razan M. El Melik, Pharm.D., R.Ph.
• Education for the Multidisciplinary Team
  Jyothsna (Jo) Giri, M.D., M.B.A., Christopher M. Kohler, M.A.N., R.N., N.E.-B.C., Tammy M. McAllister, M.A. (Moderator), & Lance J. Oyen, Pharm.D., R.Ph.

Pharmacogenomics in Practice: Analgesic/Anesthesia

• Pharmacogenomics of Analgesics
  Wayne (Nick) T. Nicholson, M.D., Pharm.D.
• Pharmacogenomics: Anesthesia
  Timothy B. Curry, M.D., Ph.D.

Pharmacogenomics in Practice: Psychiatry

• Pharmacogenomics of Antidepressants
  Adrijana Kekic, Pharm.D., R.Ph.
• Case Review: Antidepressants, SSRIs (Sertraline) and SNRIs
  Adrijana Kekic, Pharm.D., R.Ph.
• Psychiatric Pharmacogenomics: Panel Discussion
  Darryl S. Chutka, M.D. (Moderator), Eric T. Matey, Pharm.D., R.Ph., Denise M. Dupras, M.D., Ph.D., Richard Weinshilboum, M.D.

Pharmacogenomics in Practice: Cardiology/GI

• Pharmacogenomics in Cardiovascular Disease
  Naveen L. Pereira, M.D.
• Warfarin & Statin Pharmacogenomics Cases
  Jan A. Anderson, Pharm.D., R.Ph.
• PGx use in Patients with Gastroesophageal Reflux Disease
  Imad Absah, M.D.

Pharmacogenomics in Practice: Oncology/Hematology

• Pharmacogenomics in Oncology
  Eric J. Yancey, Pharm.D., R.Ph.
• Why is CYP2D6 Genotyping Ready for Primetime: Association of CYP2D6 Genotype and Breast Cancer Outcome from Large Trials
  Matthew P. Goetz, M.D.
• Dihydropyrimidine Dehydrogenase (DPD) Deficiency: Implications for 5-Fluorouracil (Capecitabine) Treatment
  Robert B. Diasio, M.D.
• Belinostat and UGT1A Polymorphism
  N. Nora Bennani, M.D.
• Case: Oncology
  Caren L. Hughes, Pharm.D., R.Ph.
• Case Study: Thiopurines/TPMT and NUDT15 in Clinical Practice
  Edward V. Loftus, Jr. M.D.

Pharmacogenomics in Practice: Transplant, Infectious Disease, Immunology, Urology

• Pharmacogenomics for Transplant Patients: Immunosuppression and Beyond
  Mira T. Keddis, M.D.
• Pharmacogenomics: Challenges with Hematopoietic Stem Cell and Liver Transplantation
  John Logan Black, M.D.
• Voriconazole Case
  Christopher J. Arendt, Pharm.D., R.Ph.
• Using Pharmacogenomics to Predict Drug Hypersensitivity
  John D. Zeuli, Pharm.D., R.Ph.
• HLA and Hypersensitivity
  Jyothsna (Jo) Giri, M.D., M.B.A.
• Gout Management: Role of Pharmacogenomics
  Denise M. Dupras, M.D., Ph.D.

Pharmacogenomics Implementation

• Significant Pharmacogenomics Cases
  Heather H. Randles, Pharm.D., R.Ph.
• Developing an Individualized Medication Plan
  Eric T. Matey, Pharm.D., R.Ph.